Guanoxan

This classification denotes a guanidine and antihypertensive agent with the molecular formula C10H13N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9V0MRL0R5Y, chemically known as guanidine, ((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)- (9ci) but generally known as guanoxan, which bears US NIH Compound Identifier 16564. European Medicines Agency schedules Guanoxan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07989MIG. World Health Organization schedules guanoxan in its Anatomical Therapeutic Chemical (ATC) Classification. GUANOXAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule guanoxan under HS 29329985 and SITC 51569. As of Q4 2014, GUANOXAN remains the US FDA Preferred Term for this commodity. SMILES: C1C(OC2=CC=CC=C2O1)CN=C(N)N.